Dr. Dubinsky is Board certified in adult neurology by the American Board of Psychiatry and Neurology with added qualifications in Clinical Neurophysiology. He is also certified by the American Board of Electrodiagnostic Medicine. He is a Fellow of the American Academy of Neurology. Dr. Dubinsky has served for six years on the Quality Standards subcommittee of the American Academy of Neurology being active in the preparation and evaluation of practice parameters. He then served six years on the Technology and Therapeutics Assessment committee of the American Academy of Neurology. Currently he is the chair of the Practice Improvement and vice-chair of the Quality Measures Reporting subcommittees of the AAN. Based upon his work for the AAN, he returned to graduate school in 2001, receiving his MPH from KU in 2004.
Dr. Dubinsky has published in the areas of neurophysiology, PET scanning, the use of botulinum and neurotoxins for the treatment of movement disorders, of which he is one of the early investigators into the use of these toxins, the treatment of movement disorders, evidence-based medicine, and neuro-epidemiology.
His clinical interests include the treatment of movement disorders, specifically dystonia, myoclonus, Huntington's Disease, and other movement disorders as well as Parkinson' Disease. He is actively involved in clinical research in Huntington's disease, Parkinson's disease, and in dystonia. One of his more unusual clinical activities is serving as the consulting neurologist for the Kansas City Zoological Gardens in Kansas City, Missouri.
Previously he served as the Program Director, Neurology Residency program (1992-1997), Associate Program Director, Clinical Neurophysiology Fellowship (2001-2003), Director, Clinical Neurophysiology Fellowship Program (2003-2007), and associate director of the Neurology Residency program (2005-2007). In 2008 he resumed his role as the director of the Neurology Residency Program .
Richard M. Dubinsky, M.D., MPH